Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada
RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2025 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) ("Fennec" or the "Company"), a specialty pharmaceutical company, today announced the closing of its non-brokered offering of its common shares i
(Financial Post, 2025-11-18T13:32:36Z)